Trial intelligence / Profile preview

Nimodipine for Prevention of Postoperative Cognitive Dysfunction in Neurosurgery

NCT02537080Terminated

Sponsor
Fakultní nemocnice Hradec Králové
Start
Sep 2015
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of nimodipine in Post-operative cognitive dysfunction (POCD) (2 arms), sponsored by Fakultní nemocnice Hradec Králové. Primary endpoint: Change in cognitive behavior. Started Sep 2015; status: terminated.

02

Drugs

nimodipine
03

Conditions

Post-operative cognitive dysfunction (POCD)

Beyond the preview

Go deeper on NCT02537080.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02537080.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call